Lin Yan, Hu Xiangming, Wang Weimian, Yu Bingyan, Zhou Langping, Zhou Yingling, Li Guang, Dong Haojian
Shantou University Medical College, Shantou, China.
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Front Cardiovasc Med. 2022 Aug 2;9:937952. doi: 10.3389/fcvm.2022.937952. eCollection 2022.
Coronary microvascular dysfunction (CMVD), an important etiology of ischemic heart disease, has been widely studied. D-dimer is a simple indicator of microthrombosis and inflammation. However, whether an increase in D-dimer is related to CMVD is still unclear.
This retrospective study consecutively enrolled patients with myocardial ischemia and excluded those with obstructive coronary artery. D-dimer was measured at admission and the TIMI myocardial perfusion grade (TMPG) was used to distinguish CMVD. Patients were divided into the two groups according to whether the D-dimer was elevated (>500 ng/ml). Logistic models and restricted cubic splines were used to explore the relationship between elevated D-dimer and CMVD.
A total of 377 patients were eventually enrolled in this study. Of these, 94 (24.9%) patients with CMVD had older age and higher D-dimer levels than those without CMVD. After full adjustment for other potential clinical risk factors, patients with high D-dimer levels (>500 ng/ml) had a 1.89-times (95% CI: 1.09-3.27) higher risk of CMVD than patients with low D-dimer levels. A non-linear relationship was found between concentrations of D-dimer and CMVD. With increased D-dimer level, the incidence of CMVD increased and then remained at a high level. Stratified analysis was performed and showed similar results.
Elevated D-dimer level is associated with the incidence of CMVD and potentially serves as a simple biomarker to facilitate the diagnosis of CMVD for patients with angina.
冠状动脉微血管功能障碍(CMVD)是缺血性心脏病的重要病因,已得到广泛研究。D - 二聚体是微血栓形成和炎症的一个简单指标。然而,D - 二聚体升高是否与CMVD相关仍不清楚。
这项回顾性研究连续纳入心肌缺血患者,并排除冠状动脉阻塞患者。入院时检测D - 二聚体,并使用心肌梗死溶栓试验(TIMI)心肌灌注分级(TMPG)来区分CMVD。根据D - 二聚体是否升高(>500 ng/ml)将患者分为两组。使用逻辑模型和受限立方样条来探讨D - 二聚体升高与CMVD之间的关系。
本研究最终共纳入377例患者。其中,94例(24.9%)CMVD患者的年龄和D - 二聚体水平高于无CMVD的患者。在对其他潜在临床风险因素进行充分调整后,D - 二聚体水平高(>500 ng/ml)的患者发生CMVD的风险比D - 二聚体水平低的患者高1.89倍(95%可信区间:1.09 - 3.27)。发现D - 二聚体浓度与CMVD之间存在非线性关系。随着D - 二聚体水平升高,CMVD的发生率增加,然后保持在高水平。进行分层分析并显示出类似结果。
D - 二聚体水平升高与CMVD的发生率相关,并可能作为一种简单的生物标志物,有助于心绞痛患者CMVD的诊断。